Clinical Trial: A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332481) titled 'A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease' on Jan. 09.

Brief Summary: The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include:

Study Duration: Up to 35 weeks. Treatment Duration: 24 weeks. Visit Frequency: every 4 weeks, with the exception of the Week 2 televisit. Study Intervention Name: Enpatoran, Placebo.

Intervention Form: Film-coated tablet.

Study Start Date: Feb. 2...